Fact CheckerSign in

NCT05919771Completed

Effects of Rock Climbing on Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 22 Aug 2024

Brief summary (registry, in English)

This research study is being conducted to understand the outcomes of participation in the Up ENDing Parkinson's rock climbing program (24 sessions, or twice per week for about 12 weeks) on walking \& mobility, hand strength \& dexterity, and psychological well-being in individuals with Parkinson's Disease (PD). The rock climbing sessions are administered and supervised by Up ENDing Parkinson's, and are tailored to the skill level of the participant. Participants will answer questionnaires and complete physical performance tests twice, first prior to beginning the sessions and then again after the 24 sessions have been completed.

Status (registry)
Completed
Study type
Observational
Enrollment
32 (actual)
First submitted
15 Jun 2023
Start date
12 Jul 2023
Primary completion date
12 Aug 2024
Lead sponsor
Marymount University
NCT number
NCT05919771

What you commit to

  • Study type: Observational
  • Participants enrolled: 32
  • From 12 Jul 2023 to the primary completion date, 12 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • neurological disease diagnosis other than PD;
  • uncontrolled cardiovascular, pulmonary, neurological, or metabolic disease which may impact the ability to exercise or in which exercise is contraindicated;
  • cognitive or psychiatric impairment precluding informed consent or ability to following instructions;

Other

  • pregnancy;
  • inability to ambulate 10 meters without assistive device or human assistance

Who the study is looking for

  • at least 18 years old
  • Diagnosis of Parkinson's disease
  • Hoehn \& Yahr score 1-3
  • able to speak and read in English;
  • able to ambulate at least 10 meters with no assistive device or human assistance

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Marymount University
Coordinator of this site? Confirm its status
ArlingtonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.